Ownership Summary
A total of 8 institutions have reported a stake in Jaguar Health, Inc. (NASDAQ:JAGX) as of September 2025, according to recent 13F filings with the SEC.
- The collective stake of institutional investors in Jaguar Health moved to 9.9% in September 2025, a shift up from the 2.1% reported for June 2025.
- In percentage terms, this reflects as a holdings change of 596.43% quarter on quarter, and a decrease of 46.67% year over year.
- The latest 13F cycle for Jaguar Health reveals that of 8 total investors, 4 funds grew their exposure, whereas 1 reduced theirs and 3 made no changes.
- Collectively, institutional investors increased their stake in Jaguar Health to 95.30K shares as of September 2025, a change that is up by 81.62K shares quarter on quarter and down 190.83K shares year over year.
- DRW Securities, LLC's holding of 90.97K shares as of September 30, 2025 makes it the primary institutional investor in Jaguar Health, owning 9.47% of the stock.
- Among the most significant buyers of Jaguar Health during September 2025 were DRW Securities, LLC (90.97K), Tower Research Capital LLC (TRC) (1.79K), SBI Securities Co., Ltd. (20), BANK OF AMERICA CORP /DE/ (10).
- Leading sellers of Jaguar Health stock in September 2025 included UBS Group AG (11.17K).
- The top 8 institutional holders of Jaguar Health for the quarter ending September 2025 included DRW Securities, LLC (90.97K), Tower Research Capital LLC (TRC) (3.38K), ROYAL BANK OF CANADA (702), SBI Securities Co., Ltd. (220), BANK OF AMERICA CORP /DE/ (14), MORGAN STANLEY (10), BlackRock, Inc. (4), UBS Group AG (1).